指南与共识胸部CT

基于共识聚类分析非小细胞肺癌患者术后无复发生存

Analysis of postoperative recurrence-free survival in non-small cell lung cancer patients based on consensus clustering.
指南 / 共识 · Clin Radiol · 2024-06-17

本研究回顾性分析2014年12月至2020年4月手术确诊的非小细胞肺癌患者CT影像组学特征,提取包含肿瘤及瘤周9毫米区域的影像组学特征,采用共识聚类将266例患者分为3个簇,比较临床病理特征差异并行Kaplan-Meier生存分析。结果显示3个簇间无复发生存期存在显著差异(P<0.001),3年累积无复发生存率分别为簇1 76.5%(95%CI 68.6-84.4)、簇2 45.9%(95%CI 33.4-58.4)、簇3 41.5%(95%CI 31.6-51.5)。基于瘤内及瘤周区域的CT影像组学共识聚类可对非小细胞肺癌患者术后复发风险进行分层。

要点

  • 基于瘤内及瘤周9毫米区域的CT影像组学共识聚类可识别3个复发风险不同的簇。
  • 3年累积无复发生存率簇1 76.5%、簇2 45.9%、簇3 41.5%,三组间差异P<0.001。
  • 病理TNM分期、PD-L1及EGFR表达状态在3个簇间存在显著差异。

核心结论

  • 基于瘤内及瘤周区域的CT影像组学共识聚类可将非小细胞肺癌术后患者分为3个复发风险不同的簇,簇间无复发生存期差异有统计学意义(P<0.001)。

研究设计与样本

  • 回顾性分析2014年12月至2020年4月手术确诊的非小细胞肺癌患者,共纳入266例,提取包含肿瘤及瘤周9毫米区域的CT影像组学特征,采用共识聚类将患者分为3个簇,比较临床病理特征差异并行Kaplan-Meier生存分析。

诊断标准与关键数值

  • 共识聚类识别3个簇:簇1 n=111,簇2 n=61,簇3 n=94。
  • 3年累积无复发生存率:簇1 76.5%(95%CI 68.6-84.4),簇2 45.9%(95%CI 33.4-58.4),簇3 41.5%(95%CI 31.6-51.5)。
  • Kaplan-Meier生存分析显示3个簇间无复发生存期差异有统计学意义(P<0.001)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

AIMS: This study aims to assess whether consensus clustering, based on computed tomography (CT) radiomics from both intratumoral and peritumoral regions, can effectively stratify the risk of non-small cell lung cancer (NSCLC) patients and predict their postoperative recurrence-free survival (RFS).

MATERIALS AND METHODS: A retrospective analysis was conducted on the data of surgical patients diagnosed with NSCLC between December 2014 and April 2020. After preprocessing CT images, radiomic features were extracted from a 9-mm region encompassing both the tumor and its peritumoral area. Consensus clustering was utilized to analyze the radiomics features and categorize patients into distinct clusters. A comparison of the differences in clinical pathological characteristics was conducted among the clusters. Kaplan-Meier survival analysis was employed to investigate differences in survival among the clusters.

RESULTS: A total of 266 patients were included in this study, and consensus clustering identified three clusters (Cluster 1: n=111, Cluster 2: n=61, Cluster 3: n=94). Multiple clinical risk factors, including pathological TNM staging, programmed cell death ligand 1 (PD-L1), and epidermal growth factor receptor (EGFR) expression status exhibit significant differences among the three clusters. Kaplan-Meier survival analysis demonstrated significant variations in RFS across the clusters (P<0.001). The 3-year cumulative recurrence-free survival rates were 76.5% (95% CI: 68.6-84.4) for Cluster 1, 45.9% (95% CI: 33.4-58.4) for Cluster 2, and 41.5% (95% CI: 31.6-51.5) for Cluster 3.

CONCLUSIONS: Consensus clustering of CT radiomics based on intratumoral and peritumoral regions can stratify the risk of postoperative recurrence in patients with NSCLC.

来源:Clin Radiol,查看原文。版权归原作者所有。

引用

  1. Tian Q, Zhou SY, Qin YH, et al. Analysis of postoperative recurrence-free survival in non-small cell lung cancer patients based on consensus clustering. Clin Radiol. 2024. PMID: 39039007. doi:10.1016/j.crad.2024.06.011

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。